The envelope (Env) trimer on the surface of human immunodeficiency virus type 1 (HIV-1) mediates fusion-dependent entry into CD4+ target cells [1,2] and thus is a primary target for antibodies to prevent infection [2,3,4,5]. The gene discussed is ERVW-1; the disease is infection.